{"data":[{"accessionNo":"0001104659-26-114447","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-10-01","reportingPerson":"Matthew D. Perry","reportingCik":null,"personType":"HC,IN","sharesOwned":2700000,"percentOfClass":6.67,"filedAt":"2026-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001104659-26-114447","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-10-01","reportingPerson":"Coastlands Capital LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":2700000,"percentOfClass":6.67,"filedAt":"2026-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001104659-26-114447","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-10-01","reportingPerson":"Coastlands Capital GP LLC","reportingCik":null,"personType":"OO","sharesOwned":2700000,"percentOfClass":6.67,"filedAt":"2026-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001104659-26-114447","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-10-01","reportingPerson":"Coastlands Capital LP","reportingCik":null,"personType":"IA,PN","sharesOwned":2700000,"percentOfClass":6.67,"filedAt":"2026-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001104659-26-114447","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-10-01","reportingPerson":"Coastlands Capital Partners LP","reportingCik":null,"personType":"PN","sharesOwned":2700000,"percentOfClass":6.67,"filedAt":"2026-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0000921895-26-002177","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":null,"personType":"IA,PN","sharesOwned":3235778,"percentOfClass":8,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0000921895-26-002177","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"BVF INC/IL","reportingCik":null,"personType":"CO","sharesOwned":3235778,"percentOfClass":8,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0000921895-26-002177","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"LAMPERT MARK N","reportingCik":null,"personType":"IN","sharesOwned":3235778,"percentOfClass":8,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0000921895-26-002177","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":null,"personType":"OO","sharesOwned":2961002,"percentOfClass":7.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001104659-26-097335","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Daniel Schneeberger","reportingCik":null,"personType":"HC,IN","sharesOwned":2238684,"percentOfClass":5.5,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001104659-26-097335","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"ADAR1 Capital Management, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":2238684,"percentOfClass":5.5,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001104659-26-097335","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"ADAR1 Capital Management GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":1832117,"percentOfClass":4.5,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0000921895-26-002177","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"BVF I GP LLC","reportingCik":null,"personType":"OO","sharesOwned":1671617,"percentOfClass":4.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0000921895-26-002177","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":null,"personType":"PN","sharesOwned":1671617,"percentOfClass":4.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001493152-26-038382","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68227Q105","securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Ortav Yehudai","reportingCik":null,"personType":"IN","sharesOwned":1438456,"percentOfClass":3.6,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001493152-26-038382","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68227Q105","securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Trails Edge Capital Partners, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":1438456,"percentOfClass":3.6,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001493152-26-038382","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68227Q105","securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Trails Edge Biotechnology Master Fund, LP","reportingCik":null,"personType":"PN","sharesOwned":1438456,"percentOfClass":3.6,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0000921895-26-002177","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"BVF II GP LLC","reportingCik":null,"personType":"OO","sharesOwned":1289385,"percentOfClass":3.2,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0000921895-26-002177","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":null,"personType":"PN","sharesOwned":1289385,"percentOfClass":3.2,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0000921895-26-002177","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"BVF Partners OS Ltd.","reportingCik":null,"personType":"CO","sharesOwned":226497,"percentOfClass":0.6,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0000921895-26-002177","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":null,"personType":"PN","sharesOwned":226497,"percentOfClass":0.6,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001617201-26-000003","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Prosight Management, LP","reportingCik":null,"personType":"IA","sharesOwned":978992,"percentOfClass":2.4,"filedAt":"2026-08-10","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001617201-26-000003","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Prosight Partners, LLC","reportingCik":null,"personType":"OO","sharesOwned":978992,"percentOfClass":2.4,"filedAt":"2026-08-10","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001617201-26-000003","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"W. Lawrence Hawkins","reportingCik":null,"personType":"HC,IN","sharesOwned":978992,"percentOfClass":2.4,"filedAt":"2026-08-10","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001617201-26-000003","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Prosight Plus Fund, LP","reportingCik":null,"personType":"PN","sharesOwned":219725,"percentOfClass":0.5,"filedAt":"2026-08-10","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001617201-26-000003","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Prosight Fund, LP","reportingCik":null,"personType":"PN","sharesOwned":45771,"percentOfClass":0.1,"filedAt":"2026-08-10","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0000921895-26-001486","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-05-19","reportingPerson":"LAMPERT MARK N","reportingCik":null,"personType":"IN","sharesOwned":2134908,"percentOfClass":5.3,"filedAt":"2026-05-27","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0000921895-26-001486","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-05-19","reportingPerson":"BVF INC/IL","reportingCik":null,"personType":"CO","sharesOwned":2134908,"percentOfClass":5.3,"filedAt":"2026-05-27","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0000921895-26-001486","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-05-19","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":null,"personType":"IA,PN","sharesOwned":2134908,"percentOfClass":5.3,"filedAt":"2026-05-27","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0000921895-26-001486","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-05-19","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":null,"personType":"OO","sharesOwned":1950078,"percentOfClass":4.8,"filedAt":"2026-05-27","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0000921895-26-001486","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-05-19","reportingPerson":"BVF I GP LLC","reportingCik":null,"personType":"OO","sharesOwned":1095373,"percentOfClass":2.7,"filedAt":"2026-05-27","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0000921895-26-001486","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-05-19","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":null,"personType":"PN","sharesOwned":1095373,"percentOfClass":2.7,"filedAt":"2026-05-27","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0000921895-26-001486","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-05-19","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":null,"personType":"PN","sharesOwned":854705,"percentOfClass":2.1,"filedAt":"2026-05-27","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0000921895-26-001486","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-05-19","reportingPerson":"BVF II GP LLC","reportingCik":null,"personType":"OO","sharesOwned":854705,"percentOfClass":2.1,"filedAt":"2026-05-27","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0000921895-26-001486","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-05-19","reportingPerson":"BVF Partners OS Ltd.","reportingCik":null,"personType":"CO","sharesOwned":153595,"percentOfClass":0.4,"filedAt":"2026-05-27","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0000921895-26-001486","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-05-19","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":null,"personType":"PN","sharesOwned":153595,"percentOfClass":0.4,"filedAt":"2026-05-27","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001104659-26-062876","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"ADAR1 Capital Management, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":2434941,"percentOfClass":6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001104659-26-062876","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Daniel Schneeberger","reportingCik":null,"personType":"HC,IN","sharesOwned":2434941,"percentOfClass":6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001104659-26-062876","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"ADAR1 Capital Management GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":2038429,"percentOfClass":5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001193125-26-146025","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"AI Biotechnology LLC","reportingCik":"0001942670","personType":"OO","sharesOwned":9091532,"percentOfClass":19.99,"filedAt":"2026-04-07","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001193125-26-146025","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Access Industries Holdings LLC","reportingCik":"0001391297","personType":"OO","sharesOwned":9091532,"percentOfClass":19.99,"filedAt":"2026-04-07","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001193125-26-146025","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Access Industries Management, LLC","reportingCik":"0001508226","personType":"OO","sharesOwned":9091532,"percentOfClass":19.99,"filedAt":"2026-04-07","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001193125-26-146025","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Len Blavatnik","reportingCik":"0001326628","personType":"IN","sharesOwned":9091532,"percentOfClass":19.99,"filedAt":"2026-04-07","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001346824-26-000096","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":4038715,"percentOfClass":9.9,"filedAt":"2026-04-07","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001346824-26-000096","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":4038715,"percentOfClass":9.9,"filedAt":"2026-04-07","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001346824-26-000096","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":4038715,"percentOfClass":9.9,"filedAt":"2026-04-07","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001346824-26-000096","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":4038715,"percentOfClass":9.9,"filedAt":"2026-04-07","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001193125-26-145912","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"StepStone Group LP","reportingCik":null,"personType":"PN","sharesOwned":2660612,"percentOfClass":6.6,"filedAt":"2026-04-07","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001193125-26-145912","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"StepStone Master G, L.P.","reportingCik":null,"personType":"PN","sharesOwned":2660612,"percentOfClass":6.6,"filedAt":"2026-04-07","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001193125-26-145912","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"StepStone VC MI-G GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":2660612,"percentOfClass":6.6,"filedAt":"2026-04-07","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001493152-26-015540","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Trails Edge Biotechnology Master Fund, LP","reportingCik":null,"personType":"PN","sharesOwned":2409638,"percentOfClass":6,"filedAt":"2026-04-07","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001493152-26-015540","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Trails Edge Capital Partners, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":2409638,"percentOfClass":6,"filedAt":"2026-04-07","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001493152-26-015540","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Ortav Yehudai","reportingCik":null,"personType":"IN","sharesOwned":2409638,"percentOfClass":6,"filedAt":"2026-04-07","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001636587-26-000021","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Common Stock, $0.0001 Par Value","eventDate":"2026-03-27","reportingPerson":"Anders Hove","reportingCik":null,"personType":"IN","sharesOwned":3924037,"percentOfClass":9.5,"filedAt":"2026-04-01","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001636587-26-000021","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Common Stock, $0.0001 Par Value","eventDate":"2026-03-27","reportingPerson":"ACORN BIOVENTURES 2, L.P.","reportingCik":null,"personType":"PN","sharesOwned":2069512,"percentOfClass":5,"filedAt":"2026-04-01","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001636587-26-000021","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Common Stock, $0.0001 Par Value","eventDate":"2026-03-27","reportingPerson":"Acorn Capital Advisors GP 2, LLC","reportingCik":null,"personType":"OO","sharesOwned":2069512,"percentOfClass":5,"filedAt":"2026-04-01","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001636587-26-000021","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Common Stock, $0.0001 Par Value","eventDate":"2026-03-27","reportingPerson":"ACORN BIOVENTURES, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1854525,"percentOfClass":4.5,"filedAt":"2026-04-01","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001636587-26-000021","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":"68277Q105","securityClass":"Common Stock, $0.0001 Par Value","eventDate":"2026-03-27","reportingPerson":"ACORN CAPITAL ADVISORS GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":1854525,"percentOfClass":4.5,"filedAt":"2026-04-01","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001104659-26-016660","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":null,"securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Daniel Schneeberger","reportingCik":null,"personType":"HC,IN","sharesOwned":1014158,"percentOfClass":7.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001104659-26-016660","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":null,"securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"ADAR1 Capital Management, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":1014158,"percentOfClass":7.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001104659-26-016660","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":null,"securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"ADAR1 Capital Management GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":793602,"percentOfClass":6.2,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0000902664-26-001088","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":null,"securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Highbridge Capital Management, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":542361,"percentOfClass":4.2,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001104659-26-016541","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":null,"securityClass":"Class A Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Kenneth Griffin","reportingCik":null,"personType":"HC,IN","sharesOwned":223125,"percentOfClass":1.7,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001104659-26-016541","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":null,"securityClass":"Class A Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Citadel Securities GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":174168,"percentOfClass":1.4,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001104659-26-016541","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":null,"securityClass":"Class A Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Citadel Securities LLC","reportingCik":null,"personType":"BD,OO","sharesOwned":174168,"percentOfClass":1.4,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001104659-26-016541","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":null,"securityClass":"Class A Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Citadel Securities Group LP","reportingCik":null,"personType":"HC,PN","sharesOwned":174168,"percentOfClass":1.4,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001104659-26-016541","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":null,"securityClass":"Class A Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Citadel Advisors Holdings LP","reportingCik":null,"personType":"HC,PN","sharesOwned":48957,"percentOfClass":0.4,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001104659-26-016541","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":null,"securityClass":"Class A Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Citadel Advisors LLC","reportingCik":null,"personType":"IA,HC,OO","sharesOwned":48957,"percentOfClass":0.4,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001104659-26-016541","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":null,"securityClass":"Class A Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Citadel GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":48957,"percentOfClass":0.4,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0000102909-26-000240","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics Inc","ticker":"OKUR","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":626593,"percentOfClass":4.87,"filedAt":"2026-01-30","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001104659-25-116660","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":null,"securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2025-11-24","reportingPerson":"W. Lawrence Hawkins","reportingCik":null,"personType":"HC,IN","sharesOwned":745649,"percentOfClass":5.8,"filedAt":"2025-11-28","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001104659-25-116660","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":null,"securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2025-11-24","reportingPerson":"Prosight Partners, LLC","reportingCik":null,"personType":"OO","sharesOwned":745649,"percentOfClass":5.8,"filedAt":"2025-11-28","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001104659-25-116660","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":null,"securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2025-11-24","reportingPerson":"Prosight Management, LP","reportingCik":null,"personType":"IA","sharesOwned":745649,"percentOfClass":5.8,"filedAt":"2025-11-28","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001104659-25-116660","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":null,"securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2025-11-24","reportingPerson":"Prosight Plus Fund, LP","reportingCik":null,"personType":"PN","sharesOwned":163487,"percentOfClass":1.3,"filedAt":"2025-11-28","canonicalUrl":"https://xoomar.com/markets/stocks/okur"},{"accessionNo":"0001104659-25-116660","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001637715","issuerName":"OnKure Therapeutics, Inc.","ticker":"OKUR","cusip":null,"securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2025-11-24","reportingPerson":"Prosight Fund, LP","reportingCik":null,"personType":"PN","sharesOwned":35514,"percentOfClass":0.3,"filedAt":"2025-11-28","canonicalUrl":"https://xoomar.com/markets/stocks/okur"}],"updatedAt":"2026-11-03T21:44:03.554Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/okur","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}